Skip to main content
Clinical Trials/KCT0004682
KCT0004682
Recruiting
未知

Evaluation of the efficacy and safety of 3D-printed personalized bioceramic (BGS-7) medical device on tne patient who underwent induced membrane technique to treat tibial bone defect (cortical bone length 1~5cm) caused in the traumatic open fracture: A prospective, single center, single arm, open label, investigator-initiated therapeutic pilot study

Koera University Guro Hospital0 sites5 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the musculo-skeletal system and connective tissue
Sponsor
Koera University Guro Hospital
Enrollment
5
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Koera University Guro Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. 19 to 70 years old
  • 2\. Patients requiring guide membrane technology to treat tibial defects (cortical bone length 1\-5 cm) in traumatic fractures
  • \- For 41\-A, 42\-A, B, C, 43\-A in the subgroup of AO / OTA Fracture and Dislocation Classification
  • \- Cortical bone length 1 \~ 5 cm, defect including more than 50% of cortical bone circumference
  • 3\. Those who are willing to participate in the study, to follow treatments and procedures, and to visit the hospital for all observational evaluations.
  • 4\. Person who voluntarily signed written consent after explaining the purpose and method of this study

Exclusion Criteria

  • 1\. Subject who with cartilage fracture at the site of application.
  • 2\. Subject who are diagnosed with the following diseases and who find it difficult to proceed with surgery
  • A. Uncontrolled diabetes, high blood pressure
  • B. Severe heart disease, severe liver dysfunction
  • C. Infectious Diseases with Risk of Recurrence
  • D. Blood diseases (leukemia, hemophilia, sepsis, etc.)
  • E. Osteomalacia, paget disease
  • F. Syphilis, severe epilepsy
  • G. Narcotic Drugs and Alcoholism
  • H. Pituitary dysfunction, (para)thyroid gland dysfunction, and other bone metabolic disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials